Skip to content
healthcare.dev

CUVRIOR

NDC 81802-001, TRIENTINE TETRAHYDROCHLORIDE, tablet, film coated, from Orphalan SA.

Product NDC
81802-001
Status
Listed
Labeler
Orphalan SA
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215760
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81802-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIENTINE TETRAHYDROCHLORIDE300 mg/1

Pharmacologic classes

Copper Chelating Activity [MoA]; Copper Chelator [EPC]; Metal Chelating Activity [MoA]

Package NDCNDC-11Package
81802-001-72818020001729 CARTON in 1 CARTON (81802-001-72) / 1 BLISTER PACK in 1 CARTON (81802-001-08) / 8 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f73feeae-62ad-401e-b9f7-5cb269127750

Use it

Look up 81802-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81802-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81802-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.